PITU is designed to temporarily isolate and transport patients with confirmed or suspected COVID-19 infection.
Arrowhead Medical Center Head of Anesthesiology, Dr. Mark Comunale, worked on developing the unit in 2015 after the outbreak of Ebola. AR Tech joined Dr. Comunale's efforts two years ago.
Currently, PITU is ready for use with FDA Emergency Use Authorization on the frontline in the battle against the novel Coronavirus.
PITU protects medical professionals, patients, and visiting family members against respiratory droplets and infection by using a negative pressure enclosure which surrounds the patient.
Patients can be treated by medical staff, and family members who are properly attired can even visit those patients.
A and R Tarpaulins Inc. is the parent company of AR Tech and AR Industries and provides products and services for medical companies, flight hardware, and ground support to various aerospace companies providing satellite launches.
A and R Tarpaulins also provides architectural products and services for homes and businesses, and industrial products for the transportation industry.
Pfizer reports positive Phase 3 data for ABRYSVO in adults at risk for RSV disease
D3 Bio announces Series A+ Round completion to advance innovative oncology pipeline
Dizal's sunvozertinib receives US FDA Breakthrough Therapy Designation
Merck launches Phase 3 trial of MK-1084 and KEYTRUDA combination in metastatic NSCLC
Trevi Therapeutics names new vice president of Clinical Development
Personalis validates NeXT Personal test for ultra-sensitive MRD detection
Merck reports lung cancer trial failed to meet endpoints
BerGenBio ASA starts Phase 2a portion of BGBC016 clinical study of bemcentinib